Nefrologie nieuws
- Efficacy and Safety of Iptacopan in Patients with Iga Nephropathy (IGAN): Interim Analysis (IA) of The Phase 3 Applause-Igan Study:
- National Kidney Foundation 2024 Spring Clinical Meeting Late-Breaking Abstracts May 14-18, 2024
- 2 Treatment with Chlorthalidone vs Hydrochlorothiazide and Renal Outcomes: The Diuretic Comparison Project (DCP):
- 1 Matching-Adjusted Indirect Comparisons of Egfr Slopes in The Protect Study With UK Radar Iga Nephropathy Population and The Control Arm of Nefigard:
- Is social deprivation associated with the peritoneal dialysis outcomes? A cohort study with REIN registry data
- Health-related quality of life in paediatric patients on peritoneal dialysis: Data from a tertiary centre
- Bacillus Calmette-Guérin–induced kidney granulomas
- Hereditary hypophosphatemic rickets with hypercalciuria (HHRH), a complex disorder in need of precision medicine
- Endogenous adenine as a key player in diabetic kidney disease progression: an integrated multiomics approach
- B-cell lymphoma with intracellular crystals: a mimic of crystal-storing histiocytosis
- Deciphering interleukin 37's therapeutic potential: insights into alleviating inflammation in autosomal dominant polycystic kidney disease
- Calprotectin, a misnomer for another player in vascular calcification
- Levamisole in childhood idiopathic nephrotic syndrome: new promises, and advocacy for global access
- in this issue
- The Case | Acute kidney injury in a patient with systemic necrotizing lesions